Chinese Herbal Medicine Ameliorated the Development of Chronic Kidney Disease in Patients with Chronic Hepatitis C: A Retrospective Population-Based Cohort Study
Table 1
Characteristics of hepatitis patients with and without CHM.
Characteristic
CHM
value
No N = 2710
Yes N = 2710
n (%)
n (%)
Gender∗
0.09
Female
1094 (40.4)
1033 (38.1)
Male
1616 (59.6)
1677 (61.9)
Age, year†
0.01
18–44
926 (34.2)
828 (30.6)
45–59
873 (32.2)
972 (35.9)
≥60
911 (33.6)
910 (33.6)
Mean (SD)
53.2 (16.1)
53.2 (14.58)
0.97
Urbanization∗
0.29
1 (highest)
677 (25)
646 (23.8)
2
792 (29.2)
835 (30.8)
3
409 (15.1)
437 (16.1)
4 (lowest)
832 (30.7)
792 (29.2)
Comorbidity∗
Hypertension
1124 (41.5)
1117 (41.2)
0.85
Diabetes mellitus
769 (28.4)
751 (27.7)
0.59
Coronary artery disease
734 (27.1)
723 (26.7)
0.74
Hyperlipidemia
789 (29.1)
776 (28.6)
0.7
Liver cirrhosis
474 (17.5)
457 (16.9)
0.54
Heart failure
123 (4.5)
113 (4.2)
0.51
Osteoporosis
367 (13.5)
359 (13.2)
0.75
Arrhythmia
310 (11.4)
289 (10.7)
0.36
PVD
66 (2.4)
65 (2.4)
0.93
Medication∗
HBV drug
121 (4.5)
123 (4.5)
0.9
HCV drug
177 (6.5)
165 (6.1)
0.5
CKD drug
1512 (55.8)
1491 (55)
0.57
DM drug
467 (17.2)
474 (17.5)
0.8
Statin
320 (11.8)
315 (11.6)
0.83
∗Chi-squared test; †t-test. Abbreviations: CHM, Chinese herbal medicine; SD, standard deviation; PVD, peripheral vascular disease; HBV, hepatitis B virus; hepatitis C virus; CKD, chronic kidney disease; DM, diabetes mellitus.
